在IB2/IIA2阶段状细胞子宫癌的激进手术前新辅助化疗的作用

Aysun Alci1, Okan Aytekin2, Burak Ersak2

  • 1Department of Gynecological Oncology, Antalya Health Science University Training and Research Hospital, Varlik m., Kazım Karabekir street, Antalya, 07100, Turkey. aysun_alci@hotmail.com.

BMC women's health
|June 22, 2024
PubMed
概括

激进手术前的新辅助化疗 (NACT) 并没有改善IB2/IIA2期宫癌患者的结果. 在这组患者中,NACT与无进展生存率的降低有关.